In Brief: Haussmann's Pharmacy warning letter
This article was originally published in The Tan Sheet
Executive Summary
Haussmann's Pharmacy warning letter: Company's catalog, "The Modern Source for Traditional Healing," makes therapeutic claims for many products that cause them to be considered "new drugs," FDA said in an Aug. 1 warning letter. The agency said it is concerned specifically with claims that Wormwood Herb is an "antiseptic, cramp or spasm reliever particularly for intestinal or menstrual cramps, fever breaker, fever reducer, and relief of intestinal disorders or ulcers" and diabetes claims for Haussmann's Tea #1. The Philadelphia-based firm said that it has removed or reworded the claims...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning